Champions Biotechnology, Inc: Tumor Xenotransplantation

Article

Douglas Burkett, PhD, president of Champion Biotechnology Inc, discusses the Biomerk Tumorgrafts� ("tumor xenograft") that is being developed by researchers at Champion.

Douglas Burkett, PhD, president of Champion Biotechnology Inc, discusses the Biomerk Tumorgrafts™ (“tumor xenograft”) that is being developed by researchers at Champion.

Related Videos
John M. Oldham, MD: A History of Personality Disorder Pathology
Etienne Sibille, PhD: Innovations in Cognitive Pathology
Roger Goldberg, MD: Impact of Dual Inhibition on Hard Exudates in DME | Image Credit: Bay Area Retina Associates
Deepayan Kar, PhD, MS: A Virtual Reality Approach to Contrast Sensitivity in AMD | Image Credit: LinkedIn
3 Barriers to Improving Clozapine Use in Treatment-Resistant Schizophrenia
Related Content
Ersilia DeFilippis, MD | Credit: Columbia University

Ersilia DeFilippis, MD: Need for Equity, Policy Change in Heart Failure Transplant

April 16th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

April 17th 2024
Podcast
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University

Understanding Trends in Hypertrophic Cardiomyopathy-Related ED Visits, with Ahmad Masri, MD, MS

April 12th 2024
Article
"New Insight with Veeral Sheth, MD" logo | Image Credit: HCPLive

New Insight: Role of Contract Research Organizations in Retina w/ Brad Doerschuk

February 29th 2024
Podcast
Experts' Perspectives: Advancements in Cardiomyopathy at ACC.24

Experts' Perspectives: Advancements in Cardiomyopathy at ACC.24

April 10th 2024
Article
Christie Ballantyne, MD | Credit: Baylor College of Medicine

Obicetrapib Works Synergistically with Ezetimibe in Statin Users, Study Finds

April 9th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.